Health-related quality of life in patients with locally recurrent or metastatic breast cancer treated with etirinotecan pegol versus treatment of physician's choice: Results from the randomised phase III BEACON trial

Chris Twelves, Javier Cortés, Joyce O'Shaughnessy, Ahmad Awada, Edith A. Perez, Seock–Ah –A Im, Patricia Gómez-Pardo, Lee S. Schwartzberg, Véronique Diéras, Denise A. Yardley, David A. Potter, Audrey Mailliez, Alvaro Moreno-Aspitia, Jin Seok Ahn, Carol Zhao, Ute Hoch, Mary Tagliaferri, Alison L. Hannah, Hope S. Rugo

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Health-related quality of life in patients with locally recurrent or metastatic breast cancer treated with etirinotecan pegol versus treatment of physician's choice: Results from the randomised phase III BEACON trial'. Together they form a unique fingerprint.

Medicine & Life Sciences